Status:
COMPLETED
Prevention of Gastric Ulcers
Lead Sponsor:
AstraZeneca
Conditions:
NSAID Associated Gastric Ulcers
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
Nonsteroidal anti-inflammatory drugs (NSAIDS) are often associated with gastric ulcers. This study looks at the prevention of these gastric ulcers with one of the three following treatment groups for ...
Eligibility Criteria
Inclusion
- No gastric or duodenal ulcer on baseline endoscopy.
- A clinical diagnosis of a chronic condition that requires daily NSAID treatment for at least 6 months.
- Other inclusion criteria, as defined in the protocol.
Exclusion
- History of esophageal, gastric or duodenal surgery, except the simple closure of an ulcer.
- History of severe liver disease, including (but not limited to) cirrhosis and acute or chronic hepatitis.
- Other criteria, as defined in the protocol.
Key Trial Info
Start Date :
March 1 2001
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2002
Estimated Enrollment :
504 Patients enrolled
Trial Details
Trial ID
NCT00629512
Start Date
March 1 2001
End Date
December 1 2002
Last Update
March 13 2009
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.